AGTX - Agentix Corp.

0.042
-0.007   -15.476%

Share volume: 40,000
Last Updated: 03-17-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$0.05
-0.01
-0.13%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 35%
Dept financing 43%
Liquidity 0%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-13.40%
3 Months
16.34%
6 Months
-3.23%
1 Year
-30.00%
2 Year
-76.27%
Key data
Stock price
$0.04
P/E Ratio 
0.00
DAY RANGE
$0.04 - $0.04
EPS 
-$0.01
52 WEEK RANGE
$0.02 - $0.08
52 WEEK CHANGE
-$17.81
MARKET CAP 
1.503 M
YIELD 
N/A
SHARES OUTSTANDING 
40.067 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
$17,525
Company detail
CEO:
Region: US
Website: agentixcorp.com
Employees: 0
IPO year: 2019
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Agentix Corp. focuses on the development and commercialization of therapeutics to treat metabolic diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix in June 2019.

Recent news